Polyreactive myelin oligodendrocyte glycoprotein antibodies: Implications for systemic autoimmunity in progressive experimental autoimmune encephalomyelitis

Journal of Neuroimmunology

Volumn 183, Issue 1-2, 2007, Pages 69-80

  Peterson, Lisa K ^a   Tsunoda, Ikuo ^a   Masaki, Takahisa ^a   Fujinami, Robert S ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

Autoantibodies; Autoimmunity; CNS demyelinating autoimmune diseases; Demyelinating diseases; Histology

Indexed keywords

IMMUNOGLOBULIN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY A4AC; MONOCLONAL ANTIBODY A4CD; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; UNCLASSIFIED DRUG;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ANTIBODY SPECIFICITY; ARTICLE; AUTOIMMUNITY; CENTRAL NERVOUS SYSTEM; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HYBRIDOMA; IMMUNOGLOBULIN DEPOSITION; IN VITRO STUDY; IN VIVO STUDY; KIDNEY; LIVER; LYMPHOCYTOTOXICITY; MOUSE; MOUSE STRAIN; NONHUMAN; OLIGODENDROGLIA; PATHOGENESIS; PRIORITY JOURNAL;

ANIMALS; ANTIBODIES, MONOCLONAL; AUTOIMMUNITY; B-LYMPHOCYTES; DISEASE MODELS, ANIMAL; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HYBRIDOMAS; IMMUNOGLOBULIN G; KIDNEY; LIVER; MICE; MYELIN-ASSOCIATED GLYCOPROTEIN; T-LYMPHOCYTES;

EID: 33846794753     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2006.11.024     Document Type: Article

References (71)

1. Achari A.N., Trontelj J.V., and Campos D.J. Multiple sclerosis and myasthenia gravis. A case report with single fiber electromyography. Neurology 26 (1976) 544-546
2. Aita J.F., Snyder D.H., and Reichl W. Myasthenia gravis and multiple sclerosis: an unusual combination of diseases. Neurology 24 (1974) 72-75
3. Amor S., Groome N., Linington C., Morris M.M., Dornmair K., Gardinier M.V., Matthieu J.-M., and Baker D. Identification of epitopes of myelin oligodendrocyte glycoprotein for the induction of experimental allergic encephalomyelitis in SJL and Biozzi AB/H mice. J. Immunol. 153 (1994) 4349-4356
4. Asakura K., Miller D.J., Pogulis R.J., Pease L.R., and Rodriguez M. Oligodendrocyte-reactive O1, O4, and HNK-1 monoclonal antibodies are encoded by germline immunoglobulin genes. Mol. Brain Res. 34 (1995) 283-293
5. Asakura K., Miller D.J., Pease L.R., and Rodriguez M. Targeting of IgMk antibodies to oligodendrocytes promotes CNS remyelination. J. Neurosci. 18 (1998) 7700-7708
6. Barres B.A., Hart I.K., Coles H.S.R., Burne J.F., Voyvodic J.T., Richardson W.D., and Raff M.C. Cell death and control of cell survival in the oligodendrocyte lineage. Cell 70 (1992) 31-46
7. Berger T., and Reindl M. Immunopathogenic and clinical relevance of antibodies against myelin oligodendrocyte glycoprotein (MOG) in multiple sclerosis. J. Neural Transm., Suppl. 60 (2000) 351-360
8. Calabresi P.A., Austin H., Racke M.K., Goodman A., Choyke P., Maloni H., and McFarland H.F. Impaired renal function in progressive multiple sclerosis. Neurology 59 (2002) 1799-1801
9. Cohen P.L. Systemic autoimmunity. In: Paul W.E. (Ed). Fundamental Immunology. Fifth edition (2003), Lippincott Williams & Wilkins, Philadelphia 1371-1399
10. Daar A.S., and Fabre J.W. Organ-specific IgM autoantibodies to liver, heart and brain in man: generalized occurrence and possible functional significance in normal individuals, and studies in patients with multiple sclerosis. Clin. Exp. Immunol. 45 (1981) 37-47
11. Detskey P.Z., Bigbee J.W., and DeVries G.H. Isolation and characterization of axolemma-enriched fractions from discrete areas of bovine CNS. Neurochem. Res. 13 (1988) 449-454
12. DeVries G.H., Anderson M.G., and Johnson D. Fractionation of isolated rat CNS myelinated axons by sucrose density gradient centrifugation in a zonal rotor. J. Neurochem. 40 (1983) 1709-1717
13. Esiri M.M. Immunoglobulin-containing cells in multiple-sclerosis plaques. Lancet 2 (1977) 478
14. Froncek M.J., and Horwitz D.A. Cytokines in the pathogenesis of systemic lupus erythematosus. In: Wallace D.J., and Hahn B.H. (Eds). Dubois' Lupus Erythematosus. Sixth edition (2002), Lippincott Williams & Wilkins, Philadelphia, PA 187-203
15. Fujinami R.S., and Oldstone M.B.A. Alterations in expression of measles virus polypeptides by antibody: molecular events in antibody-induced antigenic modulation. J. Immunol. 125 (1980) 78-85
16. Gardinier M.V., Amiguet P., Linington C., and Matthieu J.-M. Myelin/oligodendrocyte glycoprotein is a unique member of the immunoglobulin superfamily. J. Neurosci. Res. 33 (1992) 177-187
17. Genain C.P., Cannella B., Hauser S.L., and Raine C.S. Identification of autoantibodies associated with myelin damage in multiple sclerosis. Nat. Med. 5 (1999) 170-175
18. Greer J.M., Sobel R.A., Sette A., Southwood S., Lees M.B., and Kuchroo V.K. Immunogenic and encephalitogenic epitope clusters of myelin proteolipid protein. J. Immunol. 156 (1996) 371-379
19. Johnson K.P., Arrigo S.C., Nelson B.J., and Ginsberg A. Agarose electrophoresis of cerebrospinal fluid in multiple sclerosis. A simplified method for demonstrating cerebrospinal fluid oligoclonal immunoglobulin bands. Neurology 27 (1977) 273-277
20. Kabat E.A., and Freedman D.A. A study of the crystalline albumin, γ globulin and total protein in the cerebrospinal fluid of 100 cases of multiple sclerosis and in other diseases. Am. J. Med. Sci. 219 (1950) 55-64
21. Kirschning E., Jensen K., Dübel S., Rutter G., Hohenberg H., and Will H. Primary structure of the antigen-binding domains of a human oligodendrocyte-reactive IgM monoclonal antibody derived from a patient with multiple sclerosis. J. Neuroimmunol. 99 (1999) 122-130
22. Köhler G., and Milstein C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 256 (1975) 495-497
23. Kojima K., Berger T., Lassmann H., Hinze-Selch D., Zhang Y., Gehrmann J., Reske K., Wekerle H., and Linington C. Experimental autoimmune panencephalitis and uveoretinitis transferred to the Lewis rat by T lymphocytes specific for the S100b molecule, a calcium binding protein of astroglia. J. Exp. Med. 180 (1994) 817-829
24. Larsen J.P., Kvaale G., Riise T., Nyland H., and Aarli J.A. Multiple sclerosis-more than one disease?. Acta Neurol. Scand. 72 (1985) 145-150
25. Lassmann H., Brunner C., Bradl M., and Linington C. Experimental allergic encephalomyelitis: the balance between encephalitogenic T lymphocytes and demyelinating antibodies determines size and structure of demyelinated lesions. Acta Neuropathol. (Berl.) 75 (1988) 566-576
26. Libbey J.E., Peterson L.K., Tsunoda I., and Fujinami R.S. Monoclonal MOG-reactive autoantibody from progressive EAE has the characteristics of a natural antibody. J. Neuroimmunol. 173 (2006) 135-145
27. Linington C., Webb M., and Woodhams P.L. A novel myelin-associated glycoprotein defined by a mouse monoclonal antibody. J. Neuroimmunol. 6 (1984) 387-396
28. Linington C., Morgan B.P., Scolding N.J., Wilkins P., Piddlesden S., and Compston D.A. The role of complement in the pathogenesis of experimental allergic encephalomyelitis. Brain 112 (1989) 895-911
29. Linington C., Berger T., Perry L., Weerth S., Hinze-Selch D., Zhang Y., Lu H.C., Lassmann H., and Wekerle H. T cells specific for the myelin oligodendrocyte glycoprotein mediate an unusual autoimmune inflammatory response in the central nervous system. Eur. J. Immunol. 23 (1993) 1364-1372
30. Lowenthal A., Van Sande M., and Karcher D. The differential diagnosis of neurological diseases by fractionating electrophoretically the CSF G-globulins. J. New Drugs 6 (1960) 51-56
31. Lublin F.D., and Reingold S.C. Defining the clinical course of multiple sclerosis: results of an international survey. [National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis]. Neurology 46 (1996) 907-911
32. Lumsden C.E. The immunogenesis of the multiple sclerosis plaque. Brain Res. 28 (1971) 365-390
33. Matsiota P., Blancher A., Doyon B., Guilbert B., Clanet M., Kouvelas E.D., and Avrameas S. Comparative study of natural autoantibodies in the serum and cerebrospinal fluid of normal individuals and patients with multiple sclerosis and other neurological diseases. Ann. Inst. Pasteur, Immunol. 139 (1988) 99-108
34. McDonald W.I. Rachelle Fishman-Matthew Moore Lecture. The pathological and clinical dynamics of multiple sclerosis. J. Neuropathol. Exp. Neurol. 53 (1994) 338-343
35. Meloff K. Multiple sclerosis and polyarteritis (Letter to the Editor). Arch. Neurol. 37 (1980) 786
36. Mendel I., Kerlero de Rosbo N., and Ben-Nun A. A myelin oligodendrocyte glycoprotein peptide induces typical chronic experimental autoimmune encephalomyelitis in H-2b mice: fine specificity and T cell receptor Vb expression of encephalitogenic T cells. Eur. J. Immunol. 25 (1995) 1951-1959
37. Miller D.J., and Rodriguez M. A monoclonal autoantibody that promotes central nervous system remyelination in a model of multiple sclerosis is a natural autoantibody encoded by germline immunoglobulin genes. J. Immunol. 154 (1995) 2460-2469
38. Miller D.J., Sanborn K.S., Katzmann J.A., and Rodriguez M. Monoclonal autoantibodies promote central nervous system repair in an animal model of multiple sclerosis. J. Neurosci. 14 (1994) 6230-6238
39. O'Connor K.C., Appel H., Bregoli L., Call M.E., Catz I., Chan J.A., Moore N.H., Warren K.G., Wong S.J., Hafler D.A., and Wucherpfennig K.W. Antibodies from inflamed central nervous system tissue recognize myelin oligodendrocyte glycoprotein. J. Immunol. 175 (2005) 1974-1982
40. Olerup O., Hillert J., Fredrikson S., Olsson T., Kam-Hansen S., Möller E., Carlsson B., and Wallin J. Primarily chronic progressive and relapsing/remitting multiple sclerosis: two immunogenetically distinct disease entities. Proc. Natl. Acad. Sci. U. S. A. 86 (1989) 7113-7117
41. Ozaki, S., 1994. Cell lines and hybridomas. In: Delves, P.J. (Ed.), Cellular Immunology LABFAX, Oxford, UK, Academic Press. BIOS Scientific Publishers Limited, pp. 65-93.
42. Papenfuss T.L., Rogers C.J., Gienapp I., Yurrita M., McClain M., Damico N., Valo J., Song F., and Whitacre C.C. Sex differences in experimental autoimmune encephalomyelitis in multiple murine strains. J. Neuroimmunol. 150 (2004) 59-69
43. Pender M.P., Csurhes P.A., Wolfe N.P., Hooper K.D., Good M.F., McCombe P.A., and Greer J.M. Increased circulating T cell reactivity to GM3 and GQ1b gangliosides in primary progressive multiple sclerosis. J. Clin. Neurosci. 10 (2003) 63-66
44. Pham-Dinh D., Mattei M.G., Nussbaum J.L., Roussel G., Pontarotti P., Roeckel N., Mather I.H., Artzt K., Lindahl K.F., and Dautigny A. Myelin/oligodendrocyte glycoprotein is a member of a subset of the immunoglobulin superfamily encoded within the major histocompatibility complex. Proc. Natl. Acad. Sci. U. S. A. 90 (1993) 7990-7994
45. Reindl M., Linington C., Brehm U., Egg R., Dilitz E., Deisenhammer F., Poewe W., and Berger T. Antibodies against the myelin oligodendrocyte glycoprotein and the myelin basic protein in multiple sclerosis and other neurological diseases: a comparative study. Brain 122 Pt 11 (1999) 2047-2056
46. Rosenbluth J., Liang W.L., Schiff R., and Dou W.K. Spinal cord dysmyelination induced in vivo by IgM antibodies to three different myelin glycolipids. Glia 19 (1997) 58-66
47. Rosenbluth J., Schiff R., Liang W.L., Dou W.K., and Moon D. Antibody-mediated CNS demyelination: focal spinal cord lesions induced by implantation of an IgM anti-galactocerebroside-secreting hybridoma. J. Neurocytol. 28 (1999) 397-416
48. Sadatipour B.T., Greer J.M., and Pender M.P. Increased circulating antiganglioside antibodies in primary and secondary progressive multiple sclerosis. Ann. Neurol. 44 (1998) 980-983
49. Schnell L., and Schwab M.E. Axonal regeneration in the rat spinal cord produced by an antibody against myelin-associated neurite growth inhibitors. Nature 343 (1990) 269-272
50. Scott C.F., and Spitler L.E. Lymphocytotoxic antibody in multiple sclerosis: activity against T cell subsets and correlation with disease activity. Clin. Exp. Immunol. 53 (1983) 133-139
51. Shulman M., Wilde C.D., and Köhler G. A better cell line for making hybridomas secreting specific antibodies. Nature 276 (1978) 269-270
52. Storch M.K., Piddlesden S., Haltia M., Iivanainen M., Morgan P., and Lassmann H. Multiple sclerosis: in situ evidence for antibody- and complement-mediated demyelination. Ann. Neurol. 43 (1998) 465-471
53. Sun J., Link H., Olsson T., Xiao B.G., Andersson G., Ekre H.P., Linington C., and Diener P. T and B cell responses to myelin-oligodendrocyte glycoprotein in multiple sclerosis. J. Immunol. 146 (1991) 1490-1495
54. Tachovsky T.G., Lisak R.P., Koprowski H., Theofilopoulos A.N., and Dixon F.J. Circulating immune complexes in multiple sclerosis and other neurological diseases. Lancet 2 (1976) 997-999
55. Tanphaichitr K. Multiple sclerosis associated with eosinophilic vasculitis, pericarditis, and hypocomplementemia. Arch. Neurol. 37 (1980) 314-315
56. Thompson A.J., Polman C.H., Miller D.H., McDonald W.I., Brochet B., Filippi M., Montalban X., and De Sá J. Primary progressive multiple sclerosis. Brain 120 (1997) 1085-1096
57. Tsunoda I., Iwasaki Y., Terunuma H., Sako K., and Ohara Y. A comparative study of acute and chronic diseases induced by two subgroups of Theiler's murine encephalomyelitis virus. Acta Neuropathol. (Berl.) 91 (1996) 595-602
58. Tsunoda I., Kuang L.-Q., Tolley N.D., Whitton J.L., and Fujinami R.S. Enhancement of experimental allergic encephalomyelitis (EAE) by DNA immunization with myelin proteolipid protein (PLP) plasmid DNA. J. Neuropathol. Exp. Neurol. 57 (1998) 758-767
59. Tsunoda I., Kuang L.-Q., Theil D.J., and Fujinami R.S. Antibody association with a novel model for primary progressive multiple sclerosis: induction of relapsing-remitting and progressive forms of EAE in H2S mouse strains. Brain Pathol. 10 (2000) 402-418
60. Tsunoda I., Kuang L.-Q., Igenge I.Z., and Fujinami R.S. Converting relapsing remitting to secondary progressive experimental allergic encephalomyelitis (EAE) by ultraviolet B irradiation. J. Neuroimmunol. 160 (2005) 122-134
61. Tsunoda I., Libbey J.E., Kuang L.-Q., Terry E.J., and Fujinami R.S. Massive apoptosis in lymphoid organs in animal models for primary and secondary progressive multiple sclerosis. Am. J. Pathol. 167 (2005) 1631-1646
62. Wang L.-Y., and Fujinami R.S. Enhancement of EAE and induction of autoantibodies to T-cell epitopes in mice infected with a recombinant vaccinia virus encoding myelin proteolipid protein. J. Neuroimmunol. 75 (1997) 75-83
63. Warrington A.E., Asakura K., Bieber A.J., Ciric B., Van Keulen V., Kaveri S.V., Kyle R.A., Pease L.R., and Rodriguez M. Human monoclonal antibodies reactive to oligodendrocytes promote remyelination in a model of multiple sclerosis. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 6820-6825
64. Weiner H.L., and Schocket A.L. Lymphocytes in multiple sclerosis: correlation with CSF immunoglobulins and cold-reactive lymphocytotoxic antibodies. Neurology 29 (1979) 1504-1508
65. Whitaker J.N., Dowling P.C., and Cook S.D. Immunofluorescent studies of the kidney in human neurologic disorders. J. Neuropathol. Exp. Neurol. 30 (1971) 129-130
66. Willenborg D.O., and Staykova M.A. Cytokines in the pathogenesis and therapy of autoimmune encephalomyelitis and multiple sclerosis. Adv. Exp. Med. Biol. 520 (2003) 96-119
67. Williamson R.A., Burgoon M.P., Owens G.P., Ghausi O., Leclerc E., Firme L., Carlson S., Corboy J., Parren P.W., Sanna P.P., Gilden D.H., and Burton D.R. Anti-DNA antibodies are a major component of the intrathecal B cell response in multiple sclerosis. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 1793-1798
68. Winfield J.B., Winchester R.J., Wernet P., Fu S.M., and Kunkel H.G. Nature of cold-reactive antibodies to lymphocyte surface determinants in systemic lupus erythematosus. Arthritis Rheum. 18 (1975) 1-8
69. Woyciechowska J.L., and Brzosko W.J. Immunofluorescence study of brain plaques from two patients with multiple sclerosis. Neurology 27 (1977) 620-622
70. Xiao B.G., Linington C., and Link H. Antibodies to myelin-oligodendrocyte glycoprotein in cerebrospinal fluid from patients with multiple sclerosis and controls. J. Neuroimmunol. 31 (1991) 91-96
71. Zhou L., Trapp B.D., and Miller R.H. Demyelination in the central nervous system mediated by an anti-oligodendrocyte antibody. J. Neurosci. Res. 54 (1998) 158-168